DE60220642T2 - Perylenequinone zur anwendung mit immunotherapeutischen mitteln - Google Patents

Perylenequinone zur anwendung mit immunotherapeutischen mitteln Download PDF

Info

Publication number
DE60220642T2
DE60220642T2 DE60220642T DE60220642T DE60220642T2 DE 60220642 T2 DE60220642 T2 DE 60220642T2 DE 60220642 T DE60220642 T DE 60220642T DE 60220642 T DE60220642 T DE 60220642T DE 60220642 T2 DE60220642 T2 DE 60220642T2
Authority
DE
Germany
Prior art keywords
hypocrellin
amino
tumor
use according
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60220642T
Other languages
German (de)
English (en)
Other versions
DE60220642D1 (de
Inventor
Beatrice Edmonton LEVEUGLE
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Quest Pharmatech Inc
Original Assignee
Altachem Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altachem Pharma Ltd filed Critical Altachem Pharma Ltd
Publication of DE60220642D1 publication Critical patent/DE60220642D1/de
Application granted granted Critical
Publication of DE60220642T2 publication Critical patent/DE60220642T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE60220642T 2001-01-30 2002-01-29 Perylenequinone zur anwendung mit immunotherapeutischen mitteln Expired - Lifetime DE60220642T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26467701P 2001-01-30 2001-01-30
US264677P 2001-01-30
PCT/IB2002/000267 WO2002060482A2 (en) 2001-01-30 2002-01-29 Perylenequinones for use with immunotherapy agents

Publications (2)

Publication Number Publication Date
DE60220642D1 DE60220642D1 (de) 2007-07-26
DE60220642T2 true DE60220642T2 (de) 2008-02-21

Family

ID=23007123

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60220642T Expired - Lifetime DE60220642T2 (de) 2001-01-30 2002-01-29 Perylenequinone zur anwendung mit immunotherapeutischen mitteln

Country Status (9)

Country Link
US (1) US20040110846A1 (https=)
EP (1) EP1357944B1 (https=)
JP (1) JP2004529091A (https=)
CN (1) CN1665535A (https=)
AT (1) ATE364398T1 (https=)
AU (1) AU2002234809B2 (https=)
CA (1) CA2436233C (https=)
DE (1) DE60220642T2 (https=)
WO (1) WO2002060482A2 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1349965A (zh) * 2000-10-25 2002-05-22 中国科学院感光化学研究所 带有脂肪环或芳香环的脂肪胺基取代去甲氧基竹红菌素及其合成方法和用途
US6627664B2 (en) * 2001-01-30 2003-09-30 Altachem Pharma Ltd. Perylenequinones for use as sonosensitizers
AU2004297235A1 (en) 2003-12-04 2005-06-23 Vertex Pharmaceuticals Incorporated Quinoxalines useful as inhibitors of protein kinases
WO2007016762A1 (en) * 2005-08-10 2007-02-15 Quest Pharmatech Inc. Perylenequinone derivatives and uses thereof
US8454991B2 (en) * 2006-07-24 2013-06-04 Quest Pharmatech Inc. Method and device for photodynamic therapy
CN102138640B (zh) * 2011-01-14 2012-12-05 江南大学 苝醌化合物在制备防治禽类病毒饲料中的应用
CN109456210B (zh) * 2017-09-06 2020-09-25 中国科学院理化技术研究所 一种竹红菌素迫位和2-位同时氨基取代的衍生物及其制备方法和应用
CN109453408A (zh) * 2018-11-16 2019-03-12 江南大学 抗菌创伤敷料及其制备方法
CA3135291A1 (en) * 2019-03-29 2020-10-08 The Brigham And Women's Hospital, Inc. Targeted synergistic cancer immunotherapy
CN115282133A (zh) * 2021-12-06 2022-11-04 温州医科大学 竹红菌乙素在制备抗结肠癌药物中的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1015033A2 (en) * 1997-01-10 2000-07-05 AltaRex, Corp. Substituted perylenequinones for use in photodynamic therapy
GB9710049D0 (en) * 1997-05-19 1997-07-09 Nycomed Imaging As Method
DK1009413T3 (da) * 1997-09-05 2007-06-11 Univ California Anvendelse af immunstimulerende oligonukleotider til forebyggelse eller behandling af astma
EP1820514A3 (en) * 1998-06-15 2007-10-17 AltaRex Medical Corporation Therapeutic compositions that produce an immune response by altering the antigen
US20020022032A1 (en) * 1999-04-23 2002-02-21 Curry Patrick Mark Immuno-adjuvant PDT treatment of metastatic tumors
ATE290879T1 (de) * 1999-08-18 2005-04-15 Altarex Medical Corp Therapeutische antikörper gegen das muc-1 antigen und verfahren zu deren verwendung
EP1276501B9 (en) * 2000-04-25 2007-01-24 Immunex Corporation Method for treatment of tumors using photodynamic therapy
US6627664B2 (en) * 2001-01-30 2003-09-30 Altachem Pharma Ltd. Perylenequinones for use as sonosensitizers
US8034803B2 (en) * 2001-02-06 2011-10-11 Qlt Inc. Photodynamic therapy of occult age-related macular degeneration

Also Published As

Publication number Publication date
EP1357944B1 (en) 2007-06-13
CA2436233C (en) 2010-10-05
JP2004529091A (ja) 2004-09-24
ATE364398T1 (de) 2007-07-15
DE60220642D1 (de) 2007-07-26
CA2436233A1 (en) 2002-08-08
US20040110846A1 (en) 2004-06-10
AU2002234809B2 (en) 2005-04-07
EP1357944A2 (en) 2003-11-05
WO2002060482A3 (en) 2003-02-13
WO2002060482A2 (en) 2002-08-08
CN1665535A (zh) 2005-09-07

Similar Documents

Publication Publication Date Title
DE69524238T2 (de) Transfer von molekülen in das zytosol von zellen durch photosensibilisierende substanzen
DE69230285T2 (de) Methode zur verhinderung von restenosierung nach rekanalisierung von körpergefässen
DE68924215T2 (de) Wellenlängenspeziphisches, cytotoxisches Mittel.
de Annunzio et al. Susceptibility of Enterococcus faecalis and Propionibacterium acnes to antimicrobial photodynamic therapy
DE69803376T2 (de) Äthylenglykolester von monohydrobenzoporphyrinderivaten als photoaktive mittel
Sanovic et al. Low dose hypericin-PDT induces complete tumor regression in BALB/c mice bearing CT26 colon carcinoma
US20090192071A1 (en) Use of photodynamic therapy to enhance treatment with immuno-modulating agents
DE60220642T2 (de) Perylenequinone zur anwendung mit immunotherapeutischen mitteln
DE69429615T2 (de) Modulationen des immunsystems mittels psoralene, die durch sichtbares licht aktiviert werden
WO1998011827A1 (en) Modulation of wound healing by photodynamic therapy
EP0696456B1 (de) Kombination von Nekrose-induzierenden Substanzen mit Substanzen, die durch Nekrosen aktiviert werden, zur selektiven Therapie von Tumoren und entzündlichen Erkrankungen
CZ77997A3 (cs) Extrakorporální způsob selektivní redukce aktivované populace leukocytů, tělesná tekutina tímto způsobem zpracovaná a použití fotoaktivní sloučeniny
Marrelli et al. Applications of natural compounds in the photodynamic therapy of skin cancer
DE60116075T2 (de) Behandlung von tumoren mit photodynamischer therapie
Raffaghello et al. Immunoliposomal fenretinide: a novel antitumoral drug for human neuroblastoma
DE60204067T2 (de) Verwendung von Xanthenon-4-Essigsäure zur Herstellung eines Medikaments für die Behandlung von hyperproliferativer Störungen
Zimmermann et al. Effects of chlorin-mediated photodynamic therapy combined with fluoropyrimidines in vitro and in a patient
AU2002234809A1 (en) Perylenequinones for use with immunotherapy agents
Ma et al. Combination sonodynamic therapy with immunoadjuvant may be a promising new modality for cancer treatment
CN1531442A (zh) 用作光敏剂和声敏剂的苝醌
EP1476190B1 (en) Amino-substituted hypocrellins for use as sonosensitizers
US20090286865A1 (en) Potentiator of antitumoral agents in the treatment of cancer
US20050129752A1 (en) Use and manufacturing process for liposomal doxorubicin pharmaceutical composition
Alexeree Photodynamic therapy based on curcumin-mediated nanomedicines for wound healing
Songca Combinations of Photodynamic Therapy against Cancer and Microbial Infections

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: QUEST PHARMATECH, INC., ALBERTA, CA